BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 21, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Zybrestat fosbretabulin: Phase II start

OxiGene said the Gynecologic Oncology Group (GOG) will begin a Phase II trial this quarter to compare Zybrestat plus Avastin bevacizumab vs. Avastin alone....

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >